Study title: Assessment of Efficacy and Systemic Safety of a New Chlorofluorocarbon-Free Formulation of Inhaled Beclomethasone Dipropionate in Asthmatic ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY, Volume 15, Number 3, 2002
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: please see report | |||||
MAH holders: please see report | |||||
Assessment: | |||||
Active substance: BECLAMETHASONE | |||||
ATC code: | |||||
Document link: DM-RS-3303-05-00 pubblication.pdf | |||||
Document date: 2015-03-02 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |